Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lixiana Acute Stroke Evaluation Registry

NCT03494530 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03494530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03494530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lixiana Acute Stroke Evaluation Registry
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2018
Completion date
December 1, 2021
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hemorrhagic transformation stroke, ischemic stroke